Product NDC: | 42192-513 |
Proprietary Name: | ENTRE-B |
Non Proprietary Name: | BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL |
Active Ingredient(s): | 6; 10 mg/5mL; mg/5mL & nbsp; BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42192-513 |
Labeler Name: | ACELLA PHARMACEUTICALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20101011 |
Package NDC: | 42192-513-04 |
Package Description: | 118 mL in 1 BOTTLE (42192-513-04) |
NDC Code | 42192-513-04 |
Proprietary Name | ENTRE-B |
Package Description | 118 mL in 1 BOTTLE (42192-513-04) |
Product NDC | 42192-513 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20101011 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | ACELLA PHARMACEUTICALS |
Substance Name | BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 6; 10 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes |